Proteonomix Inc PROT
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 7.91M
- Market Cap
- $791.06
- Volume/Avg
- 3,610 / 17,343
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Proteonomix Inc develops pre-clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company focuses on developing therapeutics based upon the use of human cells and their derivative.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 2
- Website
- http://www.proteonomix.com
Valuation
|
Metric
|
PROT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PROT
|
|---|---|
Quick Ratio | 0.38 |
Current Ratio | 0.44 |
Interest Coverage | −8.05 |
Quick Ratio
No chart available
Profitability
|
Metric
|
PROT
|
|---|---|
Return on Assets (Normalized) | −13.89% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −43.48% |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|jwxqK$ | LOCK|p$wX? | $129B | |||
| Moderna Inc
MRNA
| LOCK|jTC##@ | LOCK|%@> | $94B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|#j<?MmW | LOCK|DBql | $82B | |||
| argenx SE ADR
ARGX
| LOCK|TX^$NQ! | LOCK|Qf | $53B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>@Pt@%s | LOCK|t< | $42B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|C?@RvDG | LOCK|!%>v | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|!fVgPjjt | LOCK|?vZkX | $27B | |||
| Incyte Corp
INCY
| LOCK|Ph#pXb | LOCK|<pg | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|!><%#v& | LOCK|>cT | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|m!TY>> | LOCK|vCw | $14B |
United States